Literature DB >> 33614786

Use of Platelet-Rich Fibrin in the Treatment of Periodontal Intrabony Defects: A Systematic Review and Meta-Analysis.

Liang Chen1,2,3, Yi Ding1,2,3, Guoping Cheng1,2,3, Sue Meng1,2,3.   

Abstract

BACKGROUND: Platelet-rich fibrin (PRF) is a kind of autologous platelet concentrate which is easy to obtain and cheap. In recent years, it has been studied to improve the effect of periodontal regeneration. However, few studies have systematically evaluated the complementary effect of PRF in the treatment of intrabony defects. The present review is aimed at systematically assessing the effects of PRF on clinical and radiological outcomes of the surgical treatment of periodontal intrabony defects.
METHODS: The protocol was registered at PROSPERO (International Prospective Register of Systematic Reviews) as CRD42020206056. An electronic search was conducted in MEDLINE, Cochrane, and EMBASE databases. Only randomized clinical trials were selected. Systematically healthy patients with two or three walls of intrabony defects were considered. Intrabony defect (IBD) depth reduction and bone fill (BF) % were set as primary outcomes while probing depth (PD) reduction, clinical attachment level (CAL) gain, and gingival margin level (GML) gain were considered as the secondary outcome. When possible, a meta-analysis was performed.
RESULTS: Eighteen articles fulfilled the inclusion criteria, and seventeen studies were quantitatively analyzed. Of 17 studies, four were rated as high risk of bias and thirteen as the moderate risk of bias. Two comparisons were set: (1) open flap debridement (OFD) combined with PRF and OFD alone and (2) bone grafting (BG) combined with PRF and BG alone. Compared to OFD alone, OFD+PRF showed significantly greater in all primary and secondary outcomes. Compared to BG alone, BG+PRF showed significantly greater in IBD depth reduction, PD reduction, CAL gain, and GML gain.
CONCLUSIONS: The use of PRF was significantly effective in the treatment of periodontal intrabony defects. The benefit of OFD+PRF may be greater than BG+PRF. PRF can promote early wound healing in periodontal surgery. As all included studies were not at low risk of bias, well-designed RCTs having a high methodological quality are needed to clarify the additional effectiveness of PRF in the treatment of intrabony defects in the future.
Copyright © 2021 Liang Chen et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33614786      PMCID: PMC7878074          DOI: 10.1155/2021/6669168

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  47 in total

1.  Platelet-Rich Fibrin Combined With a Porous Hydroxyapatite Graft for the Treatment of 3-Wall Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.

Authors:  A R Pradeep; Pavan Bajaj; Nishanth S Rao; Esha Agarwal; Savitha B Naik
Journal:  J Periodontol       Date:  2017-12       Impact factor: 6.993

2.  Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features.

Authors:  David M Dohan; Joseph Choukroun; Antoine Diss; Steve L Dohan; Anthony J J Dohan; Jaafar Mouhyi; Bruno Gogly
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-01-10

3.  Effects of platelet-rich fibrin on healing of intra-bony defects treated with anorganic bovine bone mineral.

Authors:  Yasemin Sezgin; Ahu Uraz; I Levent Taner; Rana Çulhaoğlu
Journal:  Braz Oral Res       Date:  2017-01-26

4.  Treatment of 3-wall intrabony defects in patients with chronic periodontitis with autologous platelet-rich fibrin: a randomized controlled clinical trial.

Authors:  Anuj Sharma; A R Pradeep
Journal:  J Periodontol       Date:  2011-04-05       Impact factor: 6.993

5.  Platelet rich fibrin combined with decalcified freeze-dried bone allograft for the treatment of human intrabony periodontal defects: a randomized split mouth clinical trail.

Authors:  Ashish Agarwal; Narinder Dev Gupta; Avikal Jain
Journal:  Acta Odontol Scand       Date:  2015-05-14       Impact factor: 2.331

Review 6.  Biomaterials for promoting periodontal regeneration in human intrabony defects: a systematic review.

Authors:  Anton Sculean; Dimitris Nikolidakis; George Nikou; Aleksandar Ivanovic; Iain L C Chapple; Andreas Stavropoulos
Journal:  Periodontol 2000       Date:  2015-06       Impact factor: 7.589

7.  Clinical effect of autologous platelet-rich fibrin in the treatment of intra-bony defects: a controlled clinical trial.

Authors:  Manojkumar Thorat; A R Pradeep; Borse Pallavi
Journal:  J Clin Periodontol       Date:  2011-07-21       Impact factor: 8.728

8.  Clinical and radiographic evaluation and comparison of bioactive bone alloplast morsels when used alone and in combination with platelet-rich fibrin in the treatment of periodontal intrabony defects-A randomized controlled trial.

Authors:  Girish H Bodhare; Abhay P Kolte; Rajashri A Kolte; Prerna Y Shirke
Journal:  J Periodontol       Date:  2018-12-14       Impact factor: 6.993

9.  Regenerative periodontal therapy of infrabony defects using minimally invasive surgery and a collagen-enriched bovine-derived xenograft: a 1-year prospective study on clinical and aesthetic outcome.

Authors:  Jan Cosyn; Roberto Cleymaet; Lore Hanselaer; Hugo De Bruyn
Journal:  J Clin Periodontol       Date:  2012-07-30       Impact factor: 8.728

10.  Generalizability of the added benefits of guided tissue regeneration in the treatment of deep intrabony defects. Evaluation in a multi-center randomized controlled clinical trial.

Authors:  M S Tonetti; P Cortellini; J E Suvan; P Adriaens; C Baldi; D Dubravec; A Fonzar; I Fourmousis; C Magnani; V Muller-Campanile; S Patroni; M Sanz; T Vangsted; I Zabalegui; G Pini Prato; N P Lang
Journal:  J Periodontol       Date:  1998-11       Impact factor: 6.993

View more
  4 in total

1.  Clinical and radiographic evaluation of low-speed platelet-rich fibrin (PRF) for the treatment of intra-osseous defects of stage-III periodontitis patients: a randomized controlled clinical trial.

Authors:  Yasser Ali Abdulrahman; Manal Mohamed Hosny; Ahmed Elfana; Karim Mohamed Fawzy El-Sayed
Journal:  Clin Oral Investig       Date:  2022-07-25       Impact factor: 3.606

2.  Impact of local and systemic antimicrobials on leukocyte- and platelet rich fibrin: an in vitro study.

Authors:  S A M Siawasch; C Andrade; A B Castro; W Teughels; A Temmerman; M Quirynen
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

3.  Clinical and radiographic effects of ascorbic acid-augmented platelet-rich fibrin versus platelet-rich fibrin alone in intra-osseous defects of stage-III periodontitis patients: a randomized controlled clinical trial.

Authors:  Mohamed Talaat Elbehwashy; Manal Mohamed Hosny; Ahmed Elfana; Alaa Nawar; Karim Fawzy El-Sayed
Journal:  Clin Oral Investig       Date:  2021-04-12       Impact factor: 3.573

Review 4.  The Adjunctive Use of Leucocyte- and Platelet-Rich Fibrin in Periodontal Endosseous and Furcation Defects: A Systematic Review and Meta-Analysis.

Authors:  Eudoxie Pepelassi; Maria Deligianni
Journal:  Materials (Basel)       Date:  2022-03-11       Impact factor: 3.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.